ResMed v Cochlear a two horse race
James Greenhalgh puts both these medical device success stories through their paces to see which one wins out.
Friday Fishing: Adventures in tin
On this week’s fishing expedition, Gaurav Sodhi explains why one of two tin miners is worth baiting.
QBE share purchase plan arbitrage
Even if you don’t want to increase your investment in QBE shares, you should still consider participating in the share purchase plan.
Life's only certainty suits Invocare
Even the rich can’t avoid life’s only certainty. Gareth Brown explains why he loves this business but hopes to avoid becoming a customer for a while yet.
Incitec Pivot: A smelly business
There are only two reasons to buy this stock: Either it’s cheap or fertiliser prices are about to rise. Gaurav Sodhi examines the case for each.
Friday Fishing: Transpacific SPS
In the first of a weekly feature covering new stocks, Gareth Brown, who hasn’t had much luck with recent preference share offers, fishes among older securities.
AGL Notes: Passing hat now old hat
Different week, different borrower, same old story: Too little reward for a potentially very long-term loan.
Tap Oil's trifecta
With a share price up 27% in a few months, Gaurav Sodhi tallies the transactions that have transformed Tap Oil.
Woolworths' action-packed result
Even price deflation couldn’t prevent Woolworths from reporting a reasonable result. But there’s still the chance of an upgrade if conditions worsen.
AGL versus Origin Energy
Both are thought to be safe, resilient utilities but one is far more so than the other. Gaurav Sodhi referees the contest.
Call 1300 880 160
Start a chat
Schedule a call
